Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 USD | +3.45% | +11.87% | +159.69% |
05-09 | Q32 Bio Inc. Provides Corporate Update | CI |
04-11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+159.69% | 339M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Lowers Homology Medicines PT to $15 From $25 After FDA's Clinical Hold on PheNIX Based on Clinical Observations, Maintains Buy Rating